Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Gama Explorations, Inc. ( (TSE:SKNY) ) just unveiled an announcement.
LIR Life Sciences has appointed Dr. Peter Singer, a prominent global health expert and former Special Advisor to the Director General of the World Health Organization, as Scientific Advisor to help shape its strategy for expanding access to affordable obesity treatments worldwide. The company also engaged Venture Liquidity Providers Inc. to provide market-making services for its shares on the Canadian Securities Exchange and other trading venues, aiming to support trading liquidity, and approved the grant of 2,220,000 restricted share units to directors, officers and consultants under its equity incentive plan, reinforcing both its capital markets profile and internal alignment as it advances its obesity treatment pipeline.
More about Gama Explorations, Inc.
LIR Life Sciences Corp. is a Vancouver-based life sciences company focused on researching and developing scalable, affordable treatments for obesity. Its primary products under development include a transdermal patch and other novel drug delivery systems that mimic GLP-1, a naturally occurring hormone, with a market focus on expanding global access to effective obesity therapies.
Average Trading Volume: 89,835
Technical Sentiment Signal: Buy
See more data about SKNY stock on TipRanks’ Stock Analysis page.